Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BAX

Baxter International Inc.

Healthcare | Medical - Instruments & Supplies
$22.65 +5.60 (+32.84%) as of 2026-07-14 21:19 UTC
Market Cap$11.7B
Volume6.54M
EPS (TTM)$-1.87

Baxter International Inc. (NYSE: BAX) is a $11.7B medical - instruments & supplies company trading at $22.65 (+32.8% today) — yielding 2.99%. Figures from SEC EDGAR and market feeds; updated 2026-07-14 21:19 UTC.

52-Week Range
Low $16.81High $22.75

What Baxter International Inc. does

Baxter International manufactures and sells essential healthcare products including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, injectable pharmaceuticals, surgical products, smart bed systems, patient monitoring technologies, and respiratory devices. The company distributes these products globally to hospitals, nursing homes, surgery centers, dialysis facilities, and patients at home under physician supervision. Baxter operates manufacturing facilities across multiple countries and sells its products worldwide.

Summarized from Baxter International Inc.’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$22.65
Change (1D)+5.60 (+32.84%)
Market cap$11.7B
Volume6.54M shares
52-week range$16.81 – $22.75
Valuation
EPS (TTM)$-1.87
Dividend yield2.99%
Price/book1.92×
Debt/equity1.55
Returns
52-week return+34.7%
Revenue, margins & earnings
FY2021 Net income: $1.28BFY2021 Operating expenses: $3.37BFY2021 Cost of revenue: $7.43B$12.1BFY2021FY2022: net loss $2.43B on revenue $10.1B$10.1BFY2022FY2023 Revenue: $10.4B — margin split not shown (non-operating gains)$10.4BFY2023FY2024: net loss $649M on revenue $10.6B$10.6BFY2024FY2025: net loss $957M on revenue $11.2B$11.2BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-03
  • 2026-06-03Teaff JamesPresident, CCSF-321$6.0K
  • 2026-06-03Wallace Steven P.President, Adv. SurgeryF-153$2.9K
  • 2026-06-03Zielinski Anita ASVP, Interim CFO, CAO & CntrlrA13,426—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
No 13F filings reference BAX in the last quarter.
Source: SEC EDGAR · Last checked 2026-07-14
Company news View all →
Questions this page answers

What does Baxter International Inc. do?

Baxter International manufactures and sells essential healthcare products including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, injectable pharmaceuticals, surgical products, smart bed systems, patient monitoring technologies, and respiratory devices.

What is BAX's valuation?

BAX trades at $22.65, as of 2026-07-14. It carries a 2.99% dividend yield.

When did BAX last file with the SEC?

Baxter International Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-08. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 21:19 UTC. This page is also available as JSON at /api/data?ticker=BAX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BAX and 3,500+ tickers.

Create a free account — keep BAX
For your agent
GET /api/data?ticker=BAX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt